Robert Jones, DO
Family Medicine · Phoenix, AZNPI 1144859307
Payments from drug & device makers
Across 91 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$458
- GSK$251
- Lilly USA, LLC$209
- Exact Sciences$155
- Abbott$128
- Merck$120
- plus $379 from 11 others
What the payments were for
- Food & beverage$1,701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 25 | $458 |
| GSK | 13 | $251 |
| Lilly USA, LLC | 12 | $209 |
| Exact Sciences | 8 | $155 |
| Abbott | 6 | $128 |
| Merck | 6 | $120 |
| Novo Nordisk | 4 | $68 |
| Seqirus USA Inc | 4 | $64 |
| AstraZeneca | 4 | $60 |
| Astellas Pharma US Inc | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Organon | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Medtronic | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
How this compares
$1,701 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 192 | $1,534 |
| Levothyroxine Sodium | 105 | $792 |
| Losartan Potassium | 76 | $657 |
| Metoprolol Succinate | 49 | $614 |
| Lisinopril | 56 | $516 |
| Duloxetine Hcl | 22 | $500 |
| Olmesartan Medoxomil | 23 | $466 |
| Chlorthalidone | 16 | $444 |
| Amlodipine Besylate | 50 | $433 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 22 | $368 |
| Trazodone Hcl | 31 | $352 |
| Simvastatin | 47 | $335 |
| Gabapentin | 25 | $333 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 28 | $327 |
| Tamsulosin Hcl | 13 | $286 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Phoenix
- Brock MerrittPhoenix$8.4M
- Douglas CunninghamPhoenix$4.9M
- Jeffrey ZacherPhoenix$2M
- Trisha TavaresPhoenix$1.6M
- David FrancykPhoenix$1.3M
- James BeachPhoenix$1.2M
- Peter LevinsPhoenix$971K
- Elysa ShawPhoenix$774K
- Mitchell EdelsteinPhoenix$741K
- Brian DedinskyPhoenix$589K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.